Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FANTASTIC: Fimasartan in Diabetic Chronic Kidney Disease
NCT02620306Phase 3Completed
- Sponsor
- Boryung
- Start
- Feb 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fimasartan in diabetic kidney disease (DKD), hypertension (HTN), sponsored by Boryung. Started Feb 2016; status: completed.
02
Drugs
fimasartan
03
Conditions
diabetic kidney disease (DKD)hypertension (HTN)
Beyond the preview
Go deeper on NCT02620306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02620306.